JPS606686A - Thiophene derivative and its preparation - Google Patents

Thiophene derivative and its preparation

Info

Publication number
JPS606686A
JPS606686A JP11546083A JP11546083A JPS606686A JP S606686 A JPS606686 A JP S606686A JP 11546083 A JP11546083 A JP 11546083A JP 11546083 A JP11546083 A JP 11546083A JP S606686 A JPS606686 A JP S606686A
Authority
JP
Japan
Prior art keywords
general formula
formula
reduced pressure
under reduced
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11546083A
Other languages
Japanese (ja)
Other versions
JPH0449552B2 (en
Inventor
Michihiro Kobayashi
通洋 小林
Makio Kitazawa
牧雄 北澤
Takenao Saito
斎藤 武直
Ryoji Yamamoto
亮治 山本
Hiroshi Harada
弘 原田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Kissei Yakuhin Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd, Kissei Yakuhin Kogyo KK filed Critical Kissei Pharmaceutical Co Ltd
Priority to JP11546083A priority Critical patent/JPS606686A/en
Publication of JPS606686A publication Critical patent/JPS606686A/en
Publication of JPH0449552B2 publication Critical patent/JPH0449552B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A compound shown by the formula I (R1 is H, halogen, or lower acyl; Y is alkylene; R2 is H, or lower alkyl; X is simple bond, O, methylene, or alkylidene). EXAMPLE:N-[2-(2-Thienyl)ethyl]succinic acid imide. USE:A remedy and preventive for an ulcer such as gastric ulcer, doudenal ulcer, etc. PREPARATION:An aminoalkylthiophene derivative[e.g., 2-(2-aminoethyl)thiophene, etc.] shown by the formula II is reacted with a cyclic acid anhydride (e.g., succinic anhydride, etc.) shown by the formula III preferably in an inert solvent such as xylene, etc. under reflux by heating for 10-40hr.

Description

【発明の詳細な説明】 本発明は、新規なチオフェン誘導体に関するものである
。更・に詳しく述べれば、カイヨウ治療剤として有用な
、一般式 (式中のlモ、は水素原子、ハロゲン原子または低級ア
シル基であり、Yはアルキレンであり、FuQハ水素原
子または低級アルキル基であり、Xは単なる結合、酸素
原子、メチレンまたはアルキリデンである)で表わされ
るチオフェン誘導体及びその製造方法に関するものであ
る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel thiophene derivatives. More specifically, compounds useful as anti-inflammatory agents of the general formula (in the formula, lmo is a hydrogen atom, a halogen atom, or a lower acyl group, Y is an alkylene, and FuQ is a hydrogen atom or a lower alkyl group) and X is a simple bond, an oxygen atom, methylene or alkylidene) and a method for producing the same.

本発明の一般式(1)で表わされる化合物は文献未記載
の新規化合物であり、人を含む哺乳動物にぢいて、顕著
な抗カイヨウ作用を示し、胃、十二指腸カイヨウの治療
及び予防用医薬品としてきわめて有用な化合物である。
The compound represented by the general formula (1) of the present invention is a new compound that has not been described in any literature, and it exhibits a remarkable anti-inflammatory effect in mammals including humans, and can be used as a drug for the treatment and prevention of gastric and duodenal cancer. It is an extremely useful compound.

本発明は、このように医薬品として有用なチオフェン誘
導体を提供するものであり、その製造方法をも提供する
ものである。
The present invention thus provides thiophene derivatives useful as pharmaceuticals, and also provides a method for producing the same.

本発明vc8いて、5ハロゲン原子とはフッ素原子、塩
素原子、臭素原子またはヨウ素原子である。低級アルキ
ル基とは炭素数1〜6の飽和炭化水素基であり、炭素数
が3以上の場合枝分n状または環状であってもよい。低
級アシル基とは炭素数2〜8のアシル基であり、炭素数
が4以上の場合枝分れ状または環状であってもよい。ア
ルキレンとは炭素数1〜8の飽和炭化水素鎖であり、炭
素数が2以上の場合枝分ny有していてもよい。アルキ
リデンとはメチレジの1個の水素原子が低級アルキル基
によって置換さnたものである。酸残基と。
In the VC8 of the present invention, the five halogen atoms are a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom. A lower alkyl group is a saturated hydrocarbon group having 1 to 6 carbon atoms, and when it has 3 or more carbon atoms, it may be branched n-shaped or cyclic. A lower acyl group is an acyl group having 2 to 8 carbon atoms, and when it has 4 or more carbon atoms, it may be branched or cyclic. Alkylene is a saturated hydrocarbon chain having 1 to 8 carbon atoms, and when the number of carbon atoms is 2 or more, it may have a branch ny. An alkylidene is a methylane in which one hydrogen atom is replaced by a lower alkyl group. with acid residues.

は塩素原子、臭素原子、ヨウ素原子、ベンゼンスルホニ
ルオキシ基またはp −トルエンスルホニルオキシ基な
どのような無機酸または有機酸の残基である。
is a residue of an inorganic or organic acid such as a chlorine atom, a bromine atom, an iodine atom, a benzenesulfonyloxy group or a p-toluenesulfonyloxy group.

本発明の一般式(1)で表わされるチオフェン誘導体の
抗カイヨウ作用は、アルキレンの結合位置及び長さ、環
状イミドの種類及び大きさなどによって変化する。アル
キレンの結合位置はチオフェン環の2位である場合が好
ましく、アルキレンの長さは、両環状化合物を結ぶ鎖の
炭素数が2または3であるものが好ましい。環状イミド
については、5員環のコハク酸イミド誘導体が6員環の
ジグリコニル酸イミドあるいはグルタル酸イミド誘導体
に比べ活性、毒性共にやや強い傾向を示す。
The anti-alcoholic action of the thiophene derivative represented by the general formula (1) of the present invention varies depending on the bonding position and length of the alkylene, the type and size of the cyclic imide, etc. The bonding position of the alkylene is preferably the 2-position of the thiophene ring, and the length of the alkylene is preferably such that the chain connecting both cyclic compounds has 2 or 3 carbon atoms. Regarding cyclic imides, 5-membered ring succinimide derivatives tend to be somewhat stronger in both activity and toxicity than 6-membered ring diglyconylic imide or glutaric acid imide derivatives.

本発明の一般式(1)の化合物として、例えばN−(2
−チェニルメチル)コハク酸イミド、N−[2−(2−
チェニル)エチルココハク酸イばド、N−[2−(3−
チェニル)エチルココハク酸イミド、N−[3−(2−
チェニル〕プロピル〕コハク酸イミド、2−エチル−N
、、L (2−(2−チェニル)エチルココハク酸イミ
)”、2−メチル−N−(2−(2−チェニル)エチル
ココハク酸イミド、N−[2−(5−アセチル−2−チ
ェニル]エチル〕コハク51イ< l”’b N−[2
−(5−7’ロム−2−チェニル)エチルココハク酸イ
ミド、N−[2−(2−チェニル)エチル〕グルタルイ
ミド、3−メチル−N−(2−(2−チェニル)エチル
〕グルタルイヘ)’、 N −(2−fエニルメチル)
ジグリコールイミド、N−[2−(2−チェニノヒ)エ
チル〕ジグリコールイミドなどをあげることができ、こ
nもの中でN−[2−(2−チェニル)エチル無コハク
酸イミ)’、 N −[3−(2−チェニル)フロビル
〕コハク酸イミド、2−エチル−N−(2−(2−チェ
ニル)エチルココハク酸イミド、3−メチル−N−[2
−(2−チェニル)エチル〕グルタルイミド、N−[2
−(2−チェニル)エチルコシクリコールイミドなと・
が好ましい。
As the compound of general formula (1) of the present invention, for example, N-(2
-thenylmethyl)succinimide, N-[2-(2-
chenyl)ethylsuccinic acid ibad, N-[2-(3-
chenyl)ethylsuccinimide, N-[3-(2-
Chenyl]propyl]succinimide, 2-ethyl-N
,,L (2-(2-chenyl)ethylsuccinimide)", 2-methyl-N-(2-(2-chenyl)ethylsuccinimide, N-[2-(5-acetyl-2-chenyl]ethyl) ]Amber 51i <l”'b N-[2
-(5-7'rom-2-chenyl)ethylsuccinimide, N-[2-(2-chenyl)ethyl]glutarimide, 3-methyl-N-(2-(2-chenyl)ethyl]glutarihe)' , N-(2-f enylmethyl)
Examples include diglycolimide, N-[2-(2-chenyl)ethyl]diglycolimide, among which N-[2-(2-chenyl)ethyl anosuccinimide)', N -[3-(2-chenyl)furovir]succinimide, 2-ethyl-N-(2-(2-chenyl)ethylsuccinimide, 3-methyl-N-[2
-(2-chenyl)ethyl]glutarimide, N-[2
-(2-chenyl)ethylcocylicolimide.
is preferred.

本発明の一般式(1)で表ゎさnる化合物は、例えば、
一般式 (式中のIt郡よびYは前記と同じ意味をもつ)で表わ
されるアミノアルキルチオフェン誘導体と、一般式 (式中の1(、gよびXは前記と同じ意味をもつ)で表
わされる環状酸無水物とを反応させることにより製造す
ることができる。この反応Kj6いて、一般式(2)の
化合物と一般式(3)の化合物を不活性溶媒、例えばキ
シレン中で10〜40時間加熱還流することによって1
行程で目的化合物を得ることができる。この方法は反応
及び処理の簡便さまたは容易さに2いて有利である。ま
た、一般式(2)の化合物と一般式(3)の化合物を不
活性溶媒、例えば塩化メチレン中室温で反応させて、一
般式(式中の凧、R8、xgよびYは前記と同じ意味を
もつ。ただし、瓜はカルボキシル基またはアミド基が結
合しているメチレンのいずれにおいて置換されていても
よい)で表わされるアミドカルボン酸誘導体を製し、し
かる後にこの化合物を不活性溶媒、例えばキシレン中l
θ〜40時間加熱還流することによっても目的物をM造
することができる。この方法は中間で精製を加えること
ができるため最終目的物の純度の点で有利である。
The compound represented by the general formula (1) of the present invention is, for example,
An aminoalkylthiophene derivative represented by the general formula (in which It group and Y have the same meanings as above) and an aminoalkylthiophene derivative represented by the general formula (1 (in the formula, g and X have the same meanings as above)) It can be produced by reacting a cyclic acid anhydride with a cyclic acid anhydride.In this reaction Kj6, a compound of general formula (2) and a compound of general formula (3) are heated in an inert solvent such as xylene for 10 to 40 hours. By refluxing 1
The target compound can be obtained in the process. This method has the advantage of simplicity or ease of reaction and processing. Further, the compound of general formula (2) and the compound of general formula (3) are reacted in an inert solvent, for example, methylene chloride at room temperature, and the general formula (kite, R8, xg and Y in the formula have the same meanings as above) is prepared. (However, melon may be substituted at either the carboxyl group or the methylene to which the amide group is bonded) is prepared, and then this compound is dissolved in an inert solvent such as xylene. Middle l
The target product M can also be produced by heating and refluxing for 40 hours. This method is advantageous in terms of the purity of the final target product, since purification can be performed intermediately.

本製造方法において原料として用いられる一般式(2)
のアミノアルキルチオフェン誘導体は公知化合物であり
、公知の方法によって容易に製造することができる。こ
のような化合物としては、2−アミノメチルチオフェン
、2−(2−アミノエチル)チオフェン、2−(3−ア
ミノプロピル)チオフェン、3=(2−アミノエチル)
チオフェン、5−アセチル−2−(2−アミノエチルフ
チオフエン、2−(2−7ミノエチル)−5−ブロモチ
オフェンなどをあげることができる。もう一方の原料と
して用いらnる一般式(3〕の環状酸無水物も公知化合
物であり、公知の方法によって製造することができる。
General formula (2) used as a raw material in this production method
The aminoalkylthiophene derivative is a known compound and can be easily produced by a known method. Such compounds include 2-aminomethylthiophene, 2-(2-aminoethyl)thiophene, 2-(3-aminopropyl)thiophene, 3=(2-aminoethyl)
Thiophene, 5-acetyl-2-(2-aminoethylfuthiophene, 2-(2-7minoethyl)-5-bromothiophene, etc.). ] The cyclic acid anhydride is also a known compound and can be produced by a known method.

このような化合物としては、無水コハク酸、メチル無水
コハク酸、エチル無水コハク酸、無水グルタル酸、3−
メチル無水グルタル酸、無水ジグリコール酸などをあげ
ることができる。
Such compounds include succinic anhydride, methyl succinic anhydride, ethyl succinic anhydride, glutaric anhydride, 3-
Examples include methylglutaric anhydride and diglycolic anhydride.

本発明の一般式(1)で表ゎさnる化合物は、更に、一
般式 (式中のUltOよびYは前記と同じ意味をもち、Aは
酸残基である)で表わされる化合物と、一般式(式中の
R,gよびXは前記と同じ意味をもち、Mは水素原子ま
たはアルカリ金属である)で表わされる環状イミド誘導
体とを塩基性物質の存在下または非存在下に反応させる
ことによっても製造することができる。例えば一般式(
5)の化合物と一般式(6)の化合物でMが水素原子で
ある化合物とを塩基性物質、例えば炭酸カリウムの存在
下に不活性溶媒、例えばジメチルホルムアミド中50〜
120℃で10〜20時間加熱することによって、ある
いはまた、一般式(5)の化合物と一般式(6)の化合
物でMがアルカリ金属、例えばカリウム原子である化合
物とを不活性溶媒、例えばジメチルホルムアミド中50
〜120℃で10〜20時間加熱することなどによって
目的化合物を製造することができる。本製造方法に原料
として用いられる一般式(5)及び一般式(6)の化合
物はいずれも公知化合物であり、公知の方法によって容
易に製造することができる。
The compound represented by the general formula (1) of the present invention further includes a compound represented by the general formula (in which UltO and Y have the same meanings as above, and A is an acid residue), A cyclic imide derivative represented by the general formula (in which R, g and X have the same meanings as above, and M is a hydrogen atom or an alkali metal) is reacted in the presence or absence of a basic substance. It can also be manufactured by For example, the general formula (
5) and a compound of general formula (6) in which M is a hydrogen atom are mixed in an inert solvent such as dimethylformamide in the presence of a basic substance such as potassium carbonate for 50 to
Alternatively, the compound of general formula (5) and the compound of general formula (6) in which M is an alkali metal, for example a potassium atom, are dissolved in an inert solvent, for example dimethyl 50 in formamide
The target compound can be produced by heating at ~120°C for 10 to 20 hours. The compounds of general formula (5) and general formula (6) used as raw materials in this production method are both known compounds and can be easily produced by known methods.

本発明の一般式(1)の化合物で几、がノ・ロゲン原子
あるいは低級子シル基である化合物は、一般式(1)の
化合物で■、が水素原子である化合物を通常の方法でハ
ロゲン置換あるいはアシル置換することによっても製造
することができる。例えば、一般式(1)の化合物でl
−t、が水素原子である化合物を不活性溶媒、例えば含
水酢酸中11等モルないしやや過剰モルの臭素と0〜3
0℃で反応させることにより、一般式(1)の化合物で
瓜が臭素原子である化合物を製造することができる。ま
た、一般式(1)の化合物で瓜が水素原子である化合物
を、不活性溶媒、例えば酢酸−クロロホルム混合溶媒中
、ルイス酸、例えば三フフ化ホウ素エーテル錯塩の存在
下に等モルないし過剰モルの無水酢酸と0〜30℃で反
応させることによって、一般式(1)の化合物でILl
がアセチル基である化合物を製造することができる。
Compounds of the general formula (1) of the present invention in which ⇠ and ① are hydrogen atoms or lower sil groups can be prepared by adding a halogen atom to a compound of the general formula (1) in which ① is a hydrogen atom by a conventional method. It can also be produced by substitution or acyl substitution. For example, in the compound of general formula (1)
-t is a hydrogen atom in an inert solvent, for example, aqueous acetic acid, with 11 equivalent moles to a slight excess mole of bromine and 0 to 3
By reacting at 0° C., it is possible to produce a compound of general formula (1) in which the melon is a bromine atom. Alternatively, a compound of general formula (1) in which the cucumber is a hydrogen atom is added in an inert solvent, such as an acetic acid-chloroform mixed solvent, in the presence of a Lewis acid, such as boron trifluoride ether complex salt, in an equimolar to excess molar amount. By reacting with acetic anhydride at 0 to 30°C, the compound of general formula (1) is
Compounds in which is an acetyl group can be produced.

本発明の製造方法を好適に実施するには、一般式(2)
で表わされるアミノアルキルチオフェン誘導体と、これ
と等モルの一般式(3〕で表わされる環状酸無水物とを
不活性溶媒、例えばキシレン中でl (1〜40時間加
熱還流する。反応遊子後反応液を減圧下に濃縮し、残留
物を適当な有機溶媒、例えば塩化メチレンに溶解し、希
塩酸、水、炭酸水素すI−IJウム水溶液2よび水で順
次洗い、無水硫酸マグネシウムで乾燥した後溶媒を減圧
下に留去し、残留物を適当な方法で精製して目的物を得
る。または、一般式(2)で表わされるアミノアルキル
チオフェン誘導体と、これと等モルの一般式(3)で表
わさnる環状酸無水物とを不活性溶媒、例えば塩化メチ
レン中、室温でlO分分数数時間きまぜ、反応終了後反
応混合物を適当な方法で処理して、一般式(4)で表わ
されるアミドカルボン酸誘導体を得る。これを適当な不
活性溶媒、例えばキシレン中、10〜40時間加熱還流
し、上記と同様に処理口て目的物を得る。
In order to suitably carry out the production method of the present invention, general formula (2)
An aminoalkylthiophene derivative represented by the formula (3) and an equimolar amount of the cyclic acid anhydride represented by the general formula (3) are heated under reflux for 1 to 40 hours in an inert solvent such as xylene. Concentrate the liquid under reduced pressure, dissolve the residue in a suitable organic solvent such as methylene chloride, wash successively with dilute hydrochloric acid, water, an aqueous solution of hydrogen carbonate 2 and water, dry over anhydrous magnesium sulfate, and remove the solvent. is distilled off under reduced pressure, and the residue is purified by an appropriate method to obtain the desired product.Alternatively, an aminoalkylthiophene derivative represented by general formula (2) and an equimolar amount of the aminoalkylthiophene derivative represented by general formula (3) are combined. The cyclic acid anhydride represented by the formula (4) is mixed with the cyclic acid anhydride represented by the general formula (4) in an inert solvent such as methylene chloride at room temperature for several hours. An amide carboxylic acid derivative is obtained. This is heated under reflux for 10 to 40 hours in a suitable inert solvent, such as xylene, and treated in the same manner as above to obtain the desired product.

あるいはまた、一般式(5)で表わされるチオフェン誘
導体と、これと等モルの一般式(6)で表わされる環状
イミド誘導体とを不活性溶媒、例えばジメチルホルムア
ミ)’中50〜120℃で10〜20時間加熱する。こ
の際、一般式(6)の化合物でMが水素原子である化合
物を用いる場合は、゛必要量よりやや過剰の塩基性物質
、例えば炭酸カリウムの存在下に反応を行なう。反応終
了後溶媒を減圧下に留去し、残留物に適当な溶媒、例え
ば塩化メチレンを加え、水洗、乾燥後溶媒を減圧下に留
去し、残留物を適当な方法で精製して目的物を得る。
Alternatively, a thiophene derivative represented by the general formula (5) and an equimolar amount of the cyclic imide derivative represented by the general formula (6) may be mixed in an inert solvent such as dimethylformamide at 50 to 120°C for 10 minutes. Heat for ~20 hours. At this time, when using a compound of general formula (6) in which M is a hydrogen atom, the reaction is carried out in the presence of a slightly excess basic substance, such as potassium carbonate, than the required amount. After the reaction is complete, the solvent is distilled off under reduced pressure, and a suitable solvent such as methylene chloride is added to the residue. After washing with water and drying, the solvent is distilled off under reduced pressure. The residue is purified by an appropriate method to obtain the desired product. get.

本発明の一般式(1)で表わさnる化合物は文献未記載
の新規な化合物であり、種々の動物における実験的カイ
ヨウの発生に対し特異的な抑制作用を示す。特にアスピ
リン負荷幽門結さつラットにSけるカイヨウ発現に対し
ては、体重に1 当り数ダないし百数十myで50チの
抑制効果を示す。従って本発明の一般式(1)で表わさ
れる化合物は人間を含む哺乳動物の胃、十二指腸カイヨ
ウの予防及び治療にきわめて有用である。本発明は、こ
のように医薬品として有用な、新規なチオフェン誘導体
を提供するものであり、その製造方法も合わせて提供す
るものである。
The compound represented by the general formula (1) of the present invention is a novel compound that has not been described in any literature, and exhibits a specific inhibitory effect on the occurrence of experimental calligrade in various animals. Particularly, it exhibits a suppressive effect of 50% on the expression of S in pylorus-ligated rats loaded with aspirin at several to several tens of thousands of days per body weight. Therefore, the compound represented by the general formula (1) of the present invention is extremely useful for the prevention and treatment of gastric and duodenal ulcers in mammals including humans. The present invention thus provides a novel thiophene derivative useful as a pharmaceutical, and also provides a method for producing the same.

本発明の内容を以下の参考例及び実施例によりてさらに
詳細に説明する。なお、参考例及び実施例中の化合物の
融点及び沸点はすべて未補正である。
The content of the present invention will be explained in more detail with reference to the following reference examples and examples. Note that the melting points and boiling points of the compounds in Reference Examples and Examples are all uncorrected.

参考例 エチリデンコノゾ酸ジエチル18.3.と19%パラジ
ウム炭素0.31にエタノール150罰を加え、常圧で
室温にて水素を付加させた。触媒なろ去後、ろ液を減圧
下に濃縮し、油状物のエチルコノ1り酸ジエチル129
%を得た。
Reference Example Diethyl ethylideneconozoate 18.3. 150% of ethanol was added to 0.31% of 19% palladium on carbon, and hydrogen was added at normal pressure and room temperature. After removing the catalyst by filtration, the filtrate was concentrated under reduced pressure to obtain an oily product of diethyl ethylconolate 129
I got %.

赤外線吸収スペクトル(液膜): 17 :(Ocm−” 核磁気共鳴スペクトル(90MHz 、C1)C1,)
δ: 0.91(3H,t)、1.n 〜1.8(81
−1,m)12.3〜2.9 (3H,m ) * 4
.0〜4.3 (4H,m )エチルコハク酸ジエチル
12.Oyと水酸化ナトリウム10yをエタノール50
−と水50−の混液に溶かし、室温で16時間かき混ぜ
た。。反応液を塩酸で酸性にしたのち、減圧下に濃縮し
た。残留物をアセトンに溶かし、不溶物をろ去したのち
、ろ液を減圧下に濃縮し、融点95〜96℃のエチルコ
ノゾ酸8.51を得た。
Infrared absorption spectrum (liquid film): 17: (Ocm-” Nuclear magnetic resonance spectrum (90MHz, C1) C1,)
δ: 0.91 (3H, t), 1. n ~1.8 (81
-1, m) 12.3 to 2.9 (3H, m) * 4
.. 0-4.3 (4H,m) diethyl ethylsuccinate 12. Oy and 10y of sodium hydroxide to 50y of ethanol
It was dissolved in a mixture of - and 50 - of water and stirred at room temperature for 16 hours. . The reaction solution was made acidic with hydrochloric acid and then concentrated under reduced pressure. After dissolving the residue in acetone and filtering off insoluble matter, the filtrate was concentrated under reduced pressure to obtain 8.51 ethylconozoic acid with a melting point of 95-96°C.

赤外線吸収スペクトル(KBr): 1710crn−” 核磁気共鳴スヘクトh (90MHz 、 d、−1)
MS(J )δ: 0.86(3H,t)) 1.O〜
1.8(2t(、m)。
Infrared absorption spectrum (KBr): 1710 crn-” nuclear magnetic resonance spectrum h (90 MHz, d, -1)
MS(J)δ: 0.86(3H,t)) 1. O~
1.8(2t(,m).

2.2〜2.7 (3H,m ) エチルコハク酸5.0.v無水酢910 me中で1時
間加熱還流させた。反応液を減圧下に濃縮したのち、残
留油状物を減圧蒸留し、沸点106〜107°C/7’
J’orrのエチル無水コハクrljl 3.1 y 
’l得た。
2.2-2.7 (3H, m) Ethylsuccinic acid 5.0. The mixture was heated under reflux for 1 hour in 910 ml of anhydrous vinegar. After concentrating the reaction solution under reduced pressure, the residual oil was distilled under reduced pressure to obtain a boiling point of 106-107°C/7'
J'orr's ethyl amber anhydride rljl 3.1 y
'l got it.

−赤外線吸収スペクトル(液膜): 1860crn−”、1780crI!”核磁気共鳴、
X ヘタ) h (90MHz 、 CDCl、 )δ
: 1.07(3H,t)、1.3=2.3(2H,m
)。
-Infrared absorption spectrum (liquid film): 1860crn-”, 1780crI!”Nuclear magnetic resonance,
X Heta)h (90MHz, CDCl, )δ
: 1.07(3H,t), 1.3=2.3(2H,m
).

2.5 S−3,4(:うH,m) 実施例 1 2−(2−”ミノエチル)チオフェン5.01と無水コ
ハク# 4 、Oy ’l”F ’/ L/ 7150
11J 中f 12 時間加熱還流させた。反応液を減
圧下に濃縮したのち、残留結晶を塩化メチレンに溶かし
、希堪酸、水、炭酸水素ナトリウム水溶液および水で順
次洗ったのち、無水硫酸マグネシウムで乾燥した。減圧
下に溶媒を留去したのち、残留結晶をベンゼンより再結
晶し、融点138〜140℃のN−(2−(2−4エニ
ル)エチル〕コノ−1酸4 ミ)’ 3.81を得た。
2.5 S-3,4(:UH,m) Example 1 2-(2-"minoethyl)thiophene 5.01 and anhydrous amber #4, Oy'l"F'/L/7150
The mixture was heated to reflux in 11 J for 12 hours. After the reaction solution was concentrated under reduced pressure, the remaining crystals were dissolved in methylene chloride, washed successively with dilute acid, water, aqueous sodium bicarbonate solution, and water, and then dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the remaining crystals were recrystallized from benzene to give N-(2-(2-4enyl)ethyl]cono-1 acid 4-mi)'3.81 with a melting point of 138-140°C. Obtained.

元素分析値(C工。H1□No、8として)0% Hチ
 Nチ 計算値 57,39 5.30 6.69実測値 57
,54 5,19 6.67赤外線吸収スペクトル(K
Br): 1765crn−’、17(10crn−”核磁気共鳴
スペクトル(90MHz 、CDCl、 )δ: 2.
67(4H,s)、 3.14(2H,t)。
Elemental analysis value (C engineering.H1□No.8) 0% Hchi Nchi calculated value 57,39 5.30 6.69 Actual value 57
,54 5,19 6.67 Infrared absorption spectrum (K
Br): 1765 crn-', 17(10 crn-') Nuclear magnetic resonance spectrum (90 MHz, CDCl, ) δ: 2.
67 (4H, s), 3.14 (2H, t).

3.80(2H,t ) 、 6.8〜7.2(3H,
m)実施例 2 2−(2−アミノエチル)チオフェン6.8ffトメチ
ル無水コハク酸6.11を塩化メチレン150IIll
中で室温にて17時間かき混ぜたのち、炭酸水素す) 
IJウム水溶液で抽出した。水層な、塩酸で酸性とした
のち、塩化メチレンで抽出し、水で洗ったのち、無水硫
酸マグネシウムで乾燥した。減圧下に溶媒を留去し、残
留物にギシレン100yttl fi加え、39時間加
熱還流させた。今後、反応液を炭酸水素ナトリウム水溶
液ぢよび水で洗ったのち、無水硫酸マグネシウムで乾燥
した。減圧下に溶媒を留去したのち、残留結晶なジエチ
ルエーテル−ヘキサンより再結晶し、融点31.5〜3
2℃の2−メチル−N−[2−(2−チェニル)エチル
ココハク酸イミド7.21を得た。
3.80 (2H, t), 6.8-7.2 (3H,
m) Example 2 6.8 ff of 2-(2-aminoethyl)thiophene and 6.11 ff of tomethylsuccinic anhydride were mixed with 150 IIll of methylene chloride.
After stirring for 17 hours at room temperature, add hydrogen carbonate)
Extracted with IJum aqueous solution. The aqueous layer was acidified with hydrochloric acid, extracted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 100 yttl fi of cylene was added to the residue, followed by heating under reflux for 39 hours. Thereafter, the reaction solution was washed with an aqueous sodium bicarbonate solution and water, and then dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the remaining crystals were recrystallized from diethyl ether-hexane, with a melting point of 31.5-3.
7.21 of 2-methyl-N-[2-(2-chenyl)ethylsuccinimide was obtained at 2°C.

元素分析値(C,□I−1..NO,Sとして)0% 
Hチ Nチ 計算値 59.17 5,87 6.27実測値 58
.95 5,87 6.20赤外線吸収スペクトル(K
Br): 1765crn−”、1700Crn−”核磁気共鳴ス
ペクトル(、−90MHz 、 d、−DMSO)δ:
 1.18(3H,d ) 、2.1〜3.2(5H,
rn) s3’、62 (2Hlt ) + 6.8〜
7.4 (3Hlrn )実施例 3 2−(2−アミノエチル)チオフェン6.00.とエチ
ル無水コハク酸6.04yYキシレン100d 中で1
6時間加熱還流させた。今後、反応液を炭酸水素す) 
IJウム水溶液8よび水で洗ったのち、無水硫酸マグネ
シウムで乾燥した。減圧下に溶媒を留去し、残留油状物
を減圧蒸留して、沸点140〜141 ’c/ I T
orrの2−エチル−N−[2−(2−チェニル)エチ
ル]コノ・り酸イミド8.21 y ’l 4た。
Elemental analysis value (as C, □I-1..NO, S) 0%
H-chi N-chi Calculated value 59.17 5,87 6.27 Actual value 58
.. 95 5,87 6.20 Infrared absorption spectrum (K
Br): 1765crn-", 1700crn-" Nuclear magnetic resonance spectrum (, -90MHz, d, -DMSO) δ:
1.18 (3H, d), 2.1-3.2 (5H,
rn) s3', 62 (2Hlt) + 6.8~
7.4 (3Hlrn) Example 3 2-(2-aminoethyl)thiophene 6.00. and ethyl succinic anhydride 6.04yY xylene 1 in 100d
The mixture was heated under reflux for 6 hours. From now on, the reaction solution will be hydrogenated)
After washing with IJum aqueous solution 8 and water, it was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residual oil was distilled under reduced pressure to give a boiling point of 140-141'c/IT.
orr of 2-ethyl-N-[2-(2-thenyl)ethyl]conophosphate imide 8.21 y'l 4.

元素分析値(Cユ、H,6NO,8として)C係 11
チ 〜φ 計算値 6.0,73 6.37 、 5.90実測値
 60,96 6.41 5.94赤外線吸収スペクト
ル(液膜): 1780crn−” 、1700cm−”核磁気共鳴ス
ペクトル(90MHz 、 CDCl、 )δ : ’
 0.8 3 (3H1t ) + 1.0〜2.9 
(5H,rrr) 。
Elemental analysis value (as Cyu, H, 6NO, 8) C section 11
Ch ~φ Calculated value 6.0,73 6.37, 5.90 Actual value 60,96 6.41 5.94 Infrared absorption spectrum (liquid film): 1780 crn-", 1700 cm-" Nuclear magnetic resonance spectrum (90 MHz, CDCl, )δ: '
0.8 3 (3H1t) + 1.0~2.9
(5H, rrr).

3、(16(211,t)、3.71(2+1. t)
+ 6.7〜7.15(3H,m) 実施例 4 無水コハク酸3.51を塩化メチレン22me中にけん
だ(させ、室温でかぎ混ぜながら、3−(2−アミノエ
チル)チオフェン4.5Li/、を塩化メチレン22m
A’に溶かした液を加え、1.5時間反応させた。
3, (16 (211, t), 3.71 (2 + 1. t)
+ 6.7-7.15 (3H, m) Example 4 3.51 succinic anhydride was suspended in 22 me of methylene chloride, and while stirring at room temperature, 3-(2-aminoethyl)thiophene 4. 5Li/, methylene chloride 22m
A solution dissolved in A' was added and reacted for 1.5 hours.

析出結晶なろ取し、融点125〜127.5℃の3−(
2−(3−チェニル)エチルカルバモイル〕フロピオン
酸7.71を得た。
The precipitated crystals were collected by filtration and 3-( with a melting point of 125-127.5°C
7.71 of 2-(3-chenyl)ethylcarbamoyl]furopionic acid was obtained.

元素分析値(C□。HlsNO,Sとして)0% 8%
 N係 計算値 52,84 5.77 6.16実測値 52
.62 5,71 6.11赤外線吸収スペクトル(K
Br): 3300crn−”、1690crn−”、1640C
rn−’核磁気共鳴スヘl トル(90MHz 、 d
、−DMS(J )δ: 2.1〜2.5(48,m)
、2.72(2I−1,t)。
Elemental analysis value (as C□.HlsNO,S) 0% 8%
N coefficient calculated value 52,84 5.77 6.16 Actual value 52
.. 62 5,71 6.11 Infrared absorption spectrum (K
Br): 3300crn-", 1690crn-", 1640C
rn-'Nuclear Magnetic Resonance System (90MHz, d
, -DMS(J) δ: 2.1-2.5 (48, m)
, 2.72(2I-1,t).

3.1へ3.5 (2H,m ) 、 6.9〜7.6
 (31−1,rn ) +7.92(]比br ) 
+ 12,0 (1(I Fl、−br−s )3−[
2”−(3−チェニル)エチルカルレノ(モイル〕プロ
ピオンe 7.5 y ?キシレン85m/!中で24
時間加熱還流させた。キシレンを減圧下に留去し、残留
結晶をシリカゲルカラムクロマトグラフィー(溶出溶媒
クロロホルム)で精製したのち、ベンゼンーヘギサンよ
り再結晶し、融点124〜125℃のN−[2−(3−
チェニIL、 )エチルココハク酸イミド4.31を得
た。
3.1 to 3.5 (2H, m), 6.9 to 7.6
(31-1,rn) +7.92(]ratiobr)
+ 12,0 (1(I Fl, -br-s)3-[
2”-(3-chenyl)ethylcarleno(moyl)propion e 7.5 y?24 in xylene 85m/!
The mixture was heated to reflux for an hour. After xylene was distilled off under reduced pressure and the remaining crystals were purified by silica gel column chromatography (eluent: chloroform), they were recrystallized from benzene-hegisan to give N-[2-(3-
Ceni IL, ) Ethylsuccinimide 4.31 was obtained.

元素分析値(C□。H1□NO,8として)0% 8%
 N% 計算値 57.39 5.3(L 6.69実測値 5
7.09 5.23 6.70赤外線吸収スペクトル(
KBr): 1760CIn−”、1690crn−”核磁気共鳴ス
ペクトル(90MHz 、CDCl5)δ: 2.64
(4H,s)、2.95(2H,t)。
Elemental analysis value (as C□.H1□NO,8) 0% 8%
N% Calculated value 57.39 5.3 (L 6.69 Actual value 5
7.09 5.23 6.70 Infrared absorption spectrum (
KBr): 1760CIn-", 1690crn-" Nuclear magnetic resonance spectrum (90MHz, CDCl5) δ: 2.64
(4H, s), 2.95 (2H, t).

3.80 (2H,t ) 、 −6,9−7,4(3
H,m)実施例 5 2−7ミノメチルチオフエン5.0f1.ト無水コノ1
り酸4.41を塩化メチレン1’00m/i中で、室温
にて17時間かき混ぜたのち、炭酸水素ナトリウム水溶
液で抽出した。水層な塩酸で酸性としたのち、塩化メチ
レンで抽出し、水で洗ったのち、無水硫酸マグ鼻シウム
で乾燥した。減圧下に溶媒を留去し、融点131へ13
3℃の3−(2−チェニルメチルカルバモイル)プロピ
オン酸を得り。
3.80 (2H,t), -6,9-7,4(3
H, m) Example 5 2-7minomethylthiophene 5.0f1. Anhydrous Kono 1
After stirring 4.41 g of phosphoric acid in 1'00 m/i of methylene chloride at room temperature for 17 hours, the mixture was extracted with an aqueous sodium bicarbonate solution. The aqueous layer was acidified with hydrochloric acid, extracted with methylene chloride, washed with water, and dried over anhydrous magnasium sulfate. The solvent was distilled off under reduced pressure to a melting point of 131.
Obtain 3-(2-thenylmethylcarbamoyl)propionic acid at 3°C.

赤外線吸収スペクトル(KBr): 3325crn−1,1700crn−1,1650z
−”核磁気共鳴スペクトル(90Ml−1z 、 d6
−0M8(J )δ: 2.2〜2.6(41−1,m
)、4.43(2比d)。
Infrared absorption spectrum (KBr): 3325crn-1, 1700crn-1, 1650z
-”Nuclear magnetic resonance spectrum (90Ml-1z, d6
-0M8(J)δ: 2.2~2.6(41-1, m
), 4.43 (2 ratio d).

6.8〜7.5(3H,m) 、 8.42(IH,t
 ) 。
6.8-7.5 (3H, m), 8.42 (IH, t
).

11.98(lH,br、s) 3− (2−チェニルメチルカルバモイル)プロピオン
酸をキシレン20〇−中で、15時間加熱還流させた。
11.98 (lH, br, s) 3-(2-thenylmethylcarbamoyl)propionic acid was heated to reflux in 200 mm of xylene for 15 hours.

反応液を減圧下に濃縮したのち、残留物を塩化メチレン
に溶かし炭酸水素ナトリウム水溶液ゴロよび水で洗った
のち、無水硫酸マグネシウムで乾燥した。減圧下に溶媒
を留去したのち、残留結晶をベンゼン−ヘキサンより再
結晶し、融点100へ101℃のN−(2−チェニルメ
チル)コノ−り酸イミド3.61を得た。
After the reaction solution was concentrated under reduced pressure, the residue was dissolved in methylene chloride, washed with an aqueous sodium bicarbonate solution and water, and then dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the remaining crystals were recrystallized from benzene-hexane to obtain 3.61% of N-(2-chenylmethyl)conolimide having a melting point of 100 to 101°C.

元素分析値(C,H,NO8として) Cチ H係 N% 計算値 55.36 4.65 7.17実測値 55
,73 4,66 7.17赤外線吸収スペクトル(K
Br): 1770cfn−”、1695m−” 核磁気共鳴スペクトル(90MHz 、 d、−DMS
U )δ : 2.68(4H,s)、4.70(2H
,s)、6.8〜7.5 (3H,m ) 実施例 6 コハク酸イミド2.55 と炭酸カリウム4.85.を
? 無水N、N−ジメチルホルムアミド50罰にけんだ(し
、室温でかき混ぜながら、2−クロルメチルチオフェン
3.10. Y無水N、N =ジメチルホルムアミド2
0m1VC溶かした液を加え、100℃で17時間反応
させた。反応液を減圧下に濃縮し、塩化メチレンを加え
、水洗したのち、無水硫酸′マグネシウムで乾燥した。
Elemental analysis value (as C, H, NO8) Cchi H N% Calculated value 55.36 4.65 7.17 Actual value 55
,73 4,66 7.17 Infrared absorption spectrum (K
Br): 1770cfn-", 1695m-" Nuclear magnetic resonance spectrum (90MHz, d, -DMS
U) δ: 2.68 (4H, s), 4.70 (2H
, s), 6.8-7.5 (3H, m) Example 6 Succinimide 2.55 and potassium carbonate 4.85. of? 2-chloromethylthiophene 3.10.Y anhydrous N,N = dimethylformamide 2.
A solution containing 0 ml of VC was added, and the mixture was reacted at 100° C. for 17 hours. The reaction solution was concentrated under reduced pressure, diluted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate.

減圧下に溶媒を留去したのち、93留結晶ヲクロロホル
ムージエチルエーテルーヘキサンで再結晶し、N−(2
−チェニルメチル)コハク酸イミド2,87.Y得た。
After distilling off the solvent under reduced pressure, distillate 93 crystals were recrystallized from chloroform-diethyl ether-hexane to give N-(2
-thenylmethyl)succinimide 2,87. I got Y.

このものの物性は、実施例5で得た化合物と同一である
ことを示した。
The physical properties of this product showed that it was the same as the compound obtained in Example 5.

実施例 7 2−(3−アミノプロピル)チオフェン5.Qyと無水
コ・・り51d :(,5y、を塩化メチレン100m
6中で、室温にて一夜かき混ぜたのち、炭酸水素す) 
IJウム水溶液で抽出した。水層な塩酸で酸性としたの
ち、塩化メチレンで抽出し、水で洗ったのち、無水硫酸
マグネシウムで乾燥した。減圧下に溶媒を留去し、融点
87〜88℃の3−[3−(2−チェニル)プロピルカ
ルバモイル〕プロピオン酸7.7y、を得た。
Example 7 2-(3-aminopropyl)thiophene5. Qy and anhydrous co-liquid 51d: (,5y, methylene chloride 100m
After stirring overnight at room temperature in a vacuum cleaner with hydrogen carbonate)
Extracted with IJum aqueous solution. The aqueous layer was made acidic with hydrochloric acid, extracted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 7.7 y of 3-[3-(2-chenyl)propylcarbamoyl]propionic acid having a melting point of 87 to 88°C.

赤外線吸収スペクトル(KBr): 3320ffi−”、1695crn−”、1630m
−”核磁気共鳴スペクトル(90MH7、CDCl、 
、)δ: 1.82(2H,quinl、2.3〜3.
(1(6H,m)+3.25 (2H,q )、6.5
0 (IH,br 、) 。
Infrared absorption spectrum (KBr): 3320ffi-”, 1695crn-”, 1630m
-”Nuclear magnetic resonance spectrum (90MH7, CDCl,
, ) δ: 1.82 (2H, quinl, 2.3-3.
(1 (6H, m) + 3.25 (2H, q), 6.5
0 (IH,br,).

6.7〜7.2(3H,m)、 11.45(IH,5
)3−(3−(2−チェニル)フロビルカルバモイル〕
プロピオン!7.6.にキシレ、ン150m1を加え、
13.5時間加熱還流させた。反応液を減圧下に濃縮し
たのち、残留物を塩化メチレンに溶かし、炭酸水素す)
 IJウム水溶液および水で洗ったのち、無水硫酸マグ
ネシウムで乾燥した。減圧下に溶媒を留去したのち、残
留結晶をベンゼン−ヘキサンより再結晶し、融点85〜
88℃のN−[3−(2−チェニル)プロピル]コノ−
り酸イミド3.21を得た。
6.7-7.2 (3H, m), 11.45 (IH, 5
)3-(3-(2-chenyl)furobylcarbamoyl]
Propion! 7.6. Add 150ml of xylene to the
The mixture was heated to reflux for 13.5 hours. After concentrating the reaction solution under reduced pressure, the residue was dissolved in methylene chloride and diluted with hydrogen carbonate)
After washing with an aqueous IJum solution and water, it was dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the remaining crystals were recrystallized from benzene-hexane to give a melting point of 85~
N-[3-(2-chenyl)propyl]cono-
3.21 of phosphoric acid imide was obtained.

元素分析値(C,、H,、NO,8とし乏)Cチ 8%
 N% 計算値 59.17 5,87 6.27実測値 59
,27 5,96 6.27赤外線吸収スペクトル(K
Br): 1770crn−’、1695crn−’核磁気共鳴ス
ペクトA、 (90MHz 、C1)CI、 ) ’δ
 : 2.+10(2H,quin)、2.62(4H
,S)+2.88(211,t ) 、3.61 (2
H,t ) 。
Elemental analysis value (C,, H,, NO, 8 and poor) Cchi 8%
N% Calculated value 59.17 5,87 6.27 Actual value 59
,27 5,96 6.27 Infrared absorption spectrum (K
Br): 1770crn-', 1695crn-' nuclear magnetic resonance spectrum A, (90MHz, C1)CI, )'δ
: 2. +10 (2H, quin), 2.62 (4H
,S)+2.88(211,t),3.61(2
H,t).

6.75〜7.15 (31七m) 実施例 8 N−[2−(2−チェニル)エチル]コノ\り酸イミド
3.01に酢酸15扉e1クロロホルム10ne、無水
酢酸4.7zおよび三フッ化ホウ素エチルエーテル錯塩
7,8meを加え、室温で28時間かぎ混ぜた。反応液
を水に注!、1時間かき混ぜたのち、クロロホルムで抽
出した。クロロホルム層?:01%塩酸水溶液、炭酸水
素す) IJウム水溶液および食塩水で順次読つちのち
、無水硫酸マグネシウムで乾燥した。減圧下に溶媒な留
去したのち、残留結晶をベンゼン−ヘキサンより再結晶
し、融点129.5〜131.5℃のN−[2−(5−
アセチル−2−チェニル)エチル〕コノ1り酸イミド3
.31を得た。
6.75-7.15 (317 m) Example 8 N-[2-(2-chenyl)ethyl]cono\phosphoric acid imide (3.01 parts), acetic acid (15 parts, e1, chloroform (10 parts), acetic anhydride (4.7z), and three Boron fluoride ethyl ether complex salt 7,8me was added and stirred at room temperature for 28 hours. Pour the reaction solution into water! After stirring for 1 hour, the mixture was extracted with chloroform. Chloroform layer? : 01% hydrochloric acid aqueous solution, hydrogen carbonate) After sequentially reading with IJum aqueous solution and saline, it was dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the remaining crystals were recrystallized from benzene-hexane to give N-[2-(5-
Acetyl-2-chenyl)ethyl]cono-1 phosphate imide 3
.. I got 31.

元素分析値(C1,Hl、N(J、SとしてンCチ 8
% N% 計算値 57.35 5,21 5.57実測値 57
.24 5.16 5.36赤外線吸収スペクトル(K
Br): 1760crn−”、1690crn−”、1650z
−”核磁気共鳴スペクトル(90MHz 、CDCl、
 )δ: 2.53(3H,s)、2.73(4H,s
)。
Elemental analysis values (C1, Hl, N (J, S, C) 8
% N% Calculated value 57.35 5,21 5.57 Actual value 57
.. 24 5.16 5.36 Infrared absorption spectrum (K
Br): 1760crn-", 1690crn-", 1650z
-”Nuclear magnetic resonance spectrum (90MHz, CDCl,
) δ: 2.53 (3H, s), 2.73 (4H, s
).

3.19(2H,t)、3.86(28,t)。3.19 (2H, t), 3.86 (28, t).

6.94(II−1,d)、 7.57(IH,d)実
施例 9 N−[:2−(2L4エニル〕エチル〕コハク酸イミド
3,15ffを酢酸601と水2511Llの混液に溶
かし、水冷下にかき混ぜながら、臭素2.46fを酢酸
】0−に溶かした液を滴下した。室温で5分間反応させ
たのち、反応、液を水に注ぎ、塩化メチレンで抽出し、
水で洗ったのち、無水硫酸マグネシウムで乾燥した。減
圧下に溶媒を留去したのち、残留結晶をベンゼン−ヘキ
サンより再結晶し、融点iioへ111 ℃のN−[2
−(5−ブロム−2−チェニル)エチルココハク酸イミ
ド3,90.を得た。
6.94 (II-1, d), 7.57 (IH, d) Example 9 Dissolve 3,15 ff of N-[:2-(2L4enyl]ethyl]succinimide in a mixture of 601 acetic acid and 2511 Ll of water. A solution of bromine 2.46f dissolved in acetic acid ]0- was added dropwise while stirring under water cooling.After reacting at room temperature for 5 minutes, the reaction solution was poured into water, extracted with methylene chloride,
After washing with water, it was dried with anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the remaining crystals were recrystallized from benzene-hexane and heated to a melting point of io at 111 °C.
-(5-bromo-2-chenyl)ethylsuccinimide 3,90. I got it.

元素分析値(C8゜H□。N(J、B r Sとして)
0% 8% N% 計算値 41.68 3,50 4.86実測値 41
.85 3,27 4.94赤外線吸収スペクトル(K
Br): 1760cm−” 、169.0Crn−”核磁気共鳴
スペクトル(90MHz 、C1)CI、 )δ: 2
.58(4H,s)、2.96(2H,t)s3.67
(2H,t) 、6.54(IH,d) 。
Elemental analysis value (C8゜H□.N (as J, B r S)
0% 8% N% Calculated value 41.68 3,50 4.86 Actual value 41
.. 85 3,27 4.94 Infrared absorption spectrum (K
Br): 1760 cm-", 169.0 Crn-" Nuclear magnetic resonance spectrum (90 MHz, C1) CI, ) δ: 2
.. 58 (4H, s), 2.96 (2H, t) s3.67
(2H, t), 6.54 (IH, d).

6.80 (IH,d ) 実施例 10 2−(2−アミノエチル)チオフェン5.01と無水グ
ルタル酸4.51を塩化メチレン150mJ中で、室温
にて24時間かき混ぜたのち、炭酸水素ナトリウム水溶
液で抽出した。水層な塩酸で酸性としたのち、塩化メチ
レンで抽出し、水で洗ったのち、無水硫酸マグネシウム
で乾燥した。減圧下に溶媒を留去し、融点61S−63
℃の4−[2−(2−チェニル)エチルカルバモイル)
酪酸s、3.を得た。
6.80 (IH, d) Example 10 5.01 of 2-(2-aminoethyl)thiophene and 4.51 of glutaric anhydride were stirred in 150 mJ of methylene chloride at room temperature for 24 hours, and then mixed with an aqueous sodium hydrogen carbonate solution. Extracted with. The aqueous layer was made acidic with hydrochloric acid, extracted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the melting point was 61S-63.
4-[2-(2-chenyl)ethylcarbamoyl) at °C
Butyric acid s, 3. I got it.

赤外線吸収スペクトル(KBr): 3320crn−”、1700crn−”、1640c
rn−”核磁気共鳴スペクトル(90MHz 、 d、
−DMSO)δ: 1.5〜1.9(2H,m)、2.
0〜2.35(4H。
Infrared absorption spectrum (KBr): 3320crn-", 1700crn-", 1640c
rn-” nuclear magnetic resonance spectrum (90MHz, d,
-DMSO) δ: 1.5 to 1.9 (2H, m), 2.
0-2.35 (4H.

m) s 2−92 (2H1t ) + 3.32 
(2H1q) s6.7〜7.4(3H,m)、7.9
0(IH,t)4−[2−(2−fエニル)エチルカル
バモイル〕酪酸8.3ノにキシレン150mJを加え、
39時間加熱還流させた。今後、反応液を炭酸水素ナト
リウム水溶液Sよび水で洗ったのち、無水硫酸マグネシ
ウムで乾燥した。減圧下に溶媒を留去したのち、残留結
晶をベンゼン−ヘキサンより再結晶し、融点82へ83
.5℃のN−(2−(2−チェニル)エチル〕グルタル
イεド2.71を得た。
m) s 2-92 (2H1t) + 3.32
(2H1q) s6.7-7.4 (3H, m), 7.9
Add 150 mJ of xylene to 8.3 g of 0(IH,t)4-[2-(2-fenyl)ethylcarbamoyl]butyric acid,
The mixture was heated under reflux for 39 hours. Thereafter, the reaction solution was washed with aqueous sodium bicarbonate solution S and water, and then dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the remaining crystals were recrystallized from benzene-hexane to a melting point of 82 to 83.
.. 2.71 of N-(2-(2-chenyl)ethyl)glutaride epsilon at 5°C was obtained.

元素分析値(C,、H,、NO,Sとして)Cチ 8%
 N% 計算値 59.17 5,87 6.27実測値 59
.20 5,78 6.23赤外線吸収スペクトル(K
Br): 1710CrIT−1,1670crn−”核磁気共鳴
スペクトル(90MHz 、 d、−DMS(J )δ
: 1.82(21−1,quin) 、2.60(4
H,t ) 。
Elemental analysis value (as C,, H,, NO, S) Cchi 8%
N% Calculated value 59.17 5,87 6.27 Actual value 59
.. 20 5,78 6.23 Infrared absorption spectrum (K
Br): 1710CrIT-1,1670crn-”Nuclear magnetic resonance spectrum (90MHz, d, -DMS(J)δ
: 1.82(21-1,quin), 2.60(4
H,t).

2.93(214,t)、3.88(2H,t)s6.
8〜7.4 (3H,m ) 実施例 11 2−(2−アミノエチルフチオフエン6.9Ftト3−
メチル無水グルタル酸6.9ffを塩化メチレン150
rnl中で、室温にて17時間かき混ぜたのち、炭酸水
素ナトIJウム水溶液で抽出した。水層な塩酸で酸性と
したのち、塩化メチレンで抽出し、水で洗ったのち、無
水硫酸マグネシウムで乾燥した。
2.93 (214, t), 3.88 (2H, t) s6.
8 to 7.4 (3H, m) Example 11 2-(2-aminoethylfuthiophene 6.9Ft3-
6.9 ff of methyl glutaric anhydride to 150 ml of methylene chloride
The mixture was stirred in rnl at room temperature for 17 hours, and then extracted with an aqueous solution of sodium bicarbonate. The aqueous layer was made acidic with hydrochloric acid, extracted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate.

減圧下に溶媒を留去し、油状物の3−メチル−4−C2
−< 2−−t−エニル)エチルカルバモイル〕酪酸1
4.lyを得た。
The solvent was distilled off under reduced pressure to obtain an oily product of 3-methyl-4-C2.
-<2--t-enyl)ethylcarbamoyl]butyric acid 1
4. I got ly.

赤外線吸収スペクトル(液膜): 3300crn−”、l 705crn−”、1620
crIT−”核磁気共鳴スペクトル(90MMz 、C
1)CI、 )δ: 1.02 (3H,d ) * 
2.1〜2.5(5H,m ) 。
Infrared absorption spectrum (liquid film): 3300crn-", l 705crn-", 1620
crIT-” nuclear magnetic resonance spectrum (90MMz, C
1) CI, )δ: 1.02 (3H,d) *
2.1-2.5 (5H, m).

3.05(2H,t)、3.56(2H,q)。3.05 (2H, t), 3.56 (2H, q).

6.57(IH,t ) 、6.75〜7.2(3H,
m) 。
6.57 (IH, t), 6.75-7.2 (3H,
m).

11.05(IH,5) 3−メチル−4−[2−(2−チェニル)エチルカルバ
モイル) 酪m 14.Oyにキシレン15師を加え、
24時間加熱還流させた。今後、反応液を炭酸水素す)
 IJJウム溶液および水で洗ったのち、無水硫酸マグ
ネシウムで乾燥した。減圧下に溶媒を留去したのち、残
留結晶をベンゼン−ヘキサンより再結晶し、融点61〜
62℃の3−メチル−N−(2−(2−チェニル)エチ
ル〕クルタルイミド4.11を得た。
11.05(IH,5) 3-Methyl-4-[2-(2-chenyl)ethylcarbamoyl) Butyrm 14. Add xylene 15 to Oy,
The mixture was heated under reflux for 24 hours. From now on, the reaction solution will be hydrogenated)
After washing with IJJum solution and water, it was dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the remaining crystals were recrystallized from benzene-hexane to give a melting point of 61~
3-Methyl-N-(2-(2-chenyl)ethyl)kultarimide 4.11 was obtained at 62°C.

元素分析値(C8,HlllNO,8として)0% H
チ Nチ 計算値 60.73 6,37 5.90実測値 60
,80 6.39 5.65赤外線吸収スペクトル(K
Br): 1725crn−”、1670cm−”核磁気共鳴スヘ
l ) ル(90MHz 、 d、−1)MSO)δ:
 0.93(3H,d)、2.00−3.05(7H。
Elemental analysis value (as C8, HlllNO, 8) 0% H
Chi Nchi Calculated value 60.73 6,37 5.90 Actual value 60
,80 6.39 5.65 Infrared absorption spectrum (K
Br): 1725 crn-", 1670 cm-" nuclear magnetic resonance spectrum (90 MHz, d, -1) MSO) δ:
0.93 (3H, d), 2.00-3.05 (7H.

m)、3.85(2H,t)、6.7〜7.4(3H。m), 3.85 (2H, t), 6.7-7.4 (3H.

m) 実施例 12 2−(2−アミノエチル)チオフェン3.88.と無水
ジグリコール酸3.55.をキシレン150ml中で1
7時間加熱還流させた。反応液を減圧下に濃縮したのち
、残留物を塩化メチレンに溶がし、希塩酸、水、炭酸水
素す) IJウム水水溶液上び水で順次洗ったのち、無
水硫酸マグネシウムで乾燥した。
m) Example 12 2-(2-aminoethyl)thiophene 3.88. and diglycolic anhydride 3.55. 1 in 150 ml of xylene
The mixture was heated under reflux for 7 hours. After concentrating the reaction solution under reduced pressure, the residue was dissolved in methylene chloride, washed successively with dilute hydrochloric acid, water, an aqueous solution of hydrogen carbonate, and water, and then dried over anhydrous magnesium sulfate.

減圧下に溶媒を留去し、残留結晶をシリカゲルカラムク
ロマトグラフィー(溶出溶媒、酢酸エチル:ヘンセン=
l: 1 )で精製したのち、ベンゼン−ヘキサンより
再結晶し、融点117〜119℃のN−[2−(2−チ
ェニル)エチルコシクリコールイミド3.13ffを得
た。
The solvent was distilled off under reduced pressure, and the remaining crystals were subjected to silica gel column chromatography (elution solvent, ethyl acetate: Hensen =
After purification using 1:1), the product was recrystallized from benzene-hexane to obtain 3.13 ff of N-[2-(2-chenyl)ethyl cocylicolimide with a melting point of 117 to 119°C.

元素分析値(C8゜H8,NO,Sとして)0% 8%
 N% 計算値 53.32 4,92 6.22実測値 53
,60 4,89 6.21赤外線吸収スペクトル(K
Br): 1735crn−”、1680crn−”核磁気共鳴ス
ペクトル(90MHz 、 d、−DMEO)δ: 3
.02(2H,t)、 3.92(2H,t)。
Elemental analysis value (as C8°H8, NO, S) 0% 8%
N% Calculated value 53.32 4,92 6.22 Actual value 53
,60 4,89 6.21 Infrared absorption spectrum (K
Br): 1735crn-", 1680crn-" Nuclear magnetic resonance spectrum (90MHz, d, -DMEO) δ: 3
.. 02 (2H, t), 3.92 (2H, t).

4.40 (4H,、s ) 、6.85〜7.45 
(3H,m)実施例 13 2−7ミノメチルチオフエン5.65.と無水ジグリコ
ール酸5.80.をキシレン150WLl!中で、16
時間加熱還流させた。反応液を減圧下に濃縮したのち、
残留物を塩化メチレンに溶かし、希塩酸、水、炭酸水素
す) IJJウム溶液および水で順次洗ったのち、無水
硫酸マグネシウムで乾燥した。減圧下に溶媒を留去し、
残留結晶をシリカゲルカラムクロマトグラフィー(溶出
s媒、e酸エチル:ベンゼン=’l : 1 )で精製
したのち、ベンゼン−ヘキサンより再結晶し、融点10
2〜104℃のN−(2−チェニルメチル)ジグリコー
ルイミド、5.Ox、を得た。
4.40 (4H,,s), 6.85-7.45
(3H,m) Example 13 2-7minomethylthiophene 5.65. and diglycolic anhydride 5.80. xylene 150WLl! Inside, 16
The mixture was heated to reflux for an hour. After concentrating the reaction solution under reduced pressure,
The residue was dissolved in methylene chloride, washed successively with dilute hydrochloric acid, water, hydrogen carbonate solution, and water, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure,
The remaining crystals were purified by silica gel column chromatography (elution medium: ethyl acetate: benzene = 'l: 1), and then recrystallized from benzene-hexane, with a melting point of 10.
N-(2-chenylmethyl)diglycolimide at 2-104°C, 5. Ox, was obtained.

元素分析値(c、rt、No、s トL −c )Cチ
 Hチ Nチ 計算値 51.17 4.29 6.63実測値 51
,19 4,33 6.80赤外線吸収スペクトル(K
Br): 1730crn−”、1675cm−”核磁気共鳴スペ
クトl’ (90MHz 、C1)CI、 )δ:’ 
4.35(4H9S)+ 5.10(2H,s)。
Elemental analysis value (c, rt, No, s to L -c)C Hchi Nchi Calculated value 51.17 4.29 6.63 Actual value 51
,19 4,33 6.80 Infrared absorption spectrum (K
Br): 1730 crn-", 1675 cm-" Nuclear magnetic resonance spectrum l' (90 MHz, C1) CI, ) δ:'
4.35 (4H9S) + 5.10 (2H, s).

(5,8〜7.3(3H,m) 特許出願人 キッセイ薬品工業株式会社 (C07D 413106 265:00 。(5,8~7.3 (3H, m) patent applicant Kissei Pharmaceutical Co., Ltd. (C07D 413106 265:00.

333:00 ) 0発 明 者 北澤牧雄 松本市大字芳用平田945番地 0発 明 者 山本亮治 松本市大字神林3703番地の4 0発明 者 原田弘 松本市大字原103番地333:00) 0 shots Akio Kitazawa 945 Yoshiyo Hirata, Matsumoto City 0 shots: Ryoji Yamamoto 3703-4, Oaza Kanbayashi, Matsumoto City 0 Inventor Hiroshi Harada 103 Oaza Hara, Matsumoto City

Claims (1)

【特許請求の範囲】 1)一般式 (式中の凡、は水素原子、ハロゲン原子または低級アシ
ル基であり、Yはアルキレンでil)、馬は水素原子ま
たは低級アルキル基であり、Xは単なる結合、酸素原子
、メチレンまたはアルキリデンである)で表わされるチ
オフェン誘導体。 2)一般式 (式中の瓜は水素原子、ハロゲン原子または低級アシル
基であり、Yはアルキレンである)で表わされるアミノ
アルキルチオフェン誘導体と、一般式 (式中のR1は水素原子または低級アルキル基であり、
Xは単なる結合、酸素原子、メチレンまたはアルキリデ
ンである)で表わされる環状酸無水物とを反応させるこ
とを特徴とする、一般式 (式中のltl、lt2、XおよびYは前記と同じ意味
をもつ)で表わされるチオフェン誘導体の製造方法。 3)一般式 (式中のR□は水素原子、ハロゲン原子抜たは低級アシ
ル基であり、Yはアルキレンであり、Aは酸残基である
)で表わさnる化合物と、一般式 (式中のlζは水素原子または低級アルキル基であり、
Xは単なる結合、酸素原子、メチレン筺たはアルキリデ
ンであり、Mは水素原子またはアルカリ金属である)で
表わされる環状イミド誘導体と不塩基性物質の存在下ま
たは非存在下に反応させることを特徴とする、一般式(
式中の几1、■−1XおよびYは前記と同じ意味をもつ
)で表わされるチオフェン誘導体の製造方法。
[Scope of Claims] 1) General formula (wherein is a hydrogen atom, a halogen atom, or a lower acyl group, Y is alkylene and il), H is a hydrogen atom or a lower alkyl group, and X is a simple thiophene derivatives represented by a bond, an oxygen atom, methylene or alkylidene). 2) An aminoalkylthiophene derivative represented by the general formula (in the formula, R1 is a hydrogen atom, a halogen atom, or a lower acyl group, and Y is an alkylene), and an aminoalkylthiophene derivative represented by the general formula (in the formula, R1 is a hydrogen atom or a lower alkyl group) is the basis,
X is a simple bond, an oxygen atom, methylene or alkylidene. A method for producing a thiophene derivative represented by 3) A compound represented by the general formula (in the formula, R□ is a hydrogen atom, a halogen atom excluded, or a lower acyl group, Y is an alkylene, and A is an acid residue) and a compound represented by the general formula (the formula lζ in it is a hydrogen atom or a lower alkyl group,
X is a simple bond, an oxygen atom, a methylene chain or an alkylidene, and M is a hydrogen atom or an alkali metal. , the general formula (
A method for producing a thiophene derivative represented by the formula (1, -1X and Y have the same meanings as above).
JP11546083A 1983-06-27 1983-06-27 Thiophene derivative and its preparation Granted JPS606686A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11546083A JPS606686A (en) 1983-06-27 1983-06-27 Thiophene derivative and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11546083A JPS606686A (en) 1983-06-27 1983-06-27 Thiophene derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS606686A true JPS606686A (en) 1985-01-14
JPH0449552B2 JPH0449552B2 (en) 1992-08-11

Family

ID=14663093

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11546083A Granted JPS606686A (en) 1983-06-27 1983-06-27 Thiophene derivative and its preparation

Country Status (1)

Country Link
JP (1) JPS606686A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014168522A1 (en) * 2013-04-12 2014-10-16 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014168522A1 (en) * 2013-04-12 2014-10-16 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
JP2016516766A (en) * 2013-04-12 2016-06-09 オブシェストヴォ・ス・オグラニチェンノイ・オトヴェトストヴェンノストジュ・“ファームエンタープライジーズ” Glutarimide derivatives, their use, pharmaceutical compositions based thereon and methods for producing glutarimide derivatives
US9815814B2 (en) 2013-04-12 2017-11-14 Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
US10155746B2 (en) 2013-04-12 2018-12-18 Obschestvo S Ogranichennot Otvetstvennostiyu “Pharmenterprises” Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
US10155745B2 (en) 2013-04-12 2018-12-18 Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
US10155744B2 (en) 2013-04-12 2018-12-18 Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
US10155747B2 (en) 2013-04-12 2018-12-18 Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
US10196377B2 (en) 2013-04-12 2019-02-05 Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
US10377739B2 (en) 2013-04-12 2019-08-13 Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
AU2018236805B2 (en) * 2013-04-12 2020-04-09 Obschestvo S Ogranichennoi Otvetstvennostiyu "Pharmenterprises" Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
AU2018236805C1 (en) * 2013-04-12 2020-11-05 Obschestvo S Ogranichennoi Otvetstvennostiyu "Pharmenterprises" Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

Also Published As

Publication number Publication date
JPH0449552B2 (en) 1992-08-11

Similar Documents

Publication Publication Date Title
CA1326023C (en) 4-oxo-1,4-dihydronicotinic acid derivatives and salts thereof, process for producing the same, and antibacterial agents containing the same
HU194166B (en) Process for preparing 3-acyl-2-oxindole derivatives
SU1282818A3 (en) Method of producing orthocondensed derivatives of pyrrole
JPS606686A (en) Thiophene derivative and its preparation
US5712393A (en) Derivatives of 2-aminobenzenesulphonic acid and of 2-aminobenzenesulphonyl chloride, their preparation and their use as synthetic intermediates
DK147917B (en) TRICYCLIC 2,4,6-TRYODANILIDES USED AS XENTIC CONTRACTING AGENTS AND ROENTENCING CONTRACTING COMPANY CONTAINING THESE COMPOUNDS
JPS6019317B2 (en) Thienothiazine derivative and method for producing the same
CA1147324A (en) Antibacterial amide compounds and process means for producing the same
KR920006785B1 (en) Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
FI80459C (en) NYA 3- ELLER 5- (3-PYRIDYL) SUBSTITUTE 1H, 3H-PYRROLO / 1,2-C / THIAZOLE-7-CARBOXYLSYROR, VILKA AER MELLAN PRODUKTOR
JPS60120888A (en) Cephem derivative
US4118491A (en) 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
JPH0269485A (en) Cephalosporin derivative
JPH0780812B2 (en) Azulene derivative thromboxane synthetase inhibitor and process for producing the same
JPH0753704B2 (en) Process for producing phenylmalonic acid monoanilide derivative and 3-phenyl-2-quinolone derivative
JPS62116539A (en) Production of optically active alpha-haloalkyl-aryl-ketone
JPH0329068B2 (en)
JPS6081182A (en) Thiophene derivative and production thereof
KR850000430B1 (en) Process for preparing 6-substituted pyranone compounds
US4171368A (en) 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
NO157697B (en) ANALOGICAL PROCEDURE FOR PREPARING NON-STEROIDAL COMPOUNDS WITH ANTI-INFLAMMATORY AND ANALGESIC EFFECT.
JPH0527617B2 (en)
JPS59122486A (en) 2-methylchromone derivative and its preparation
JPH01128986A (en) 3-pyridinioalkylthiocephalosporin derivative
JPS5852995B2 (en) Method for producing furfural derivatives